Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Holding GLUE?
Track your performance easily

Monte Rosa Therapeutics (GLUE) Stock Investors

257 Followers
Based on 766,001 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GLUE
On average, investors allocate 0.00% of their portfolios to GLUE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,001 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GLUE

2.2%
Last 7
Days
7.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GLUE, out of 766,001 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GLUE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.14%
$3.89
Reduced
20.44%
$5.45
Increased
0.37%
$3.95
Increased
17.36%
$4.87
Based on the activity of 14,644 investors who made their portfolios public
The table shows changes in GLUE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GLUE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.92%
+3.23%
+5.26%
7.67B
Healthcare
Abbott Laboratories
3.56%
+0.57%
+13.94%
199.98B
Healthcare
Caterpillar
4.51%
+0.74%
+1.12%
197.08B
Industrials
Enphase Energy
4.63%
-0.99%
+3.65%
9.67B
Technology
Synopsys
3.55%
-0.94%
+10.46%
88.11B
Technology
Zscaler
3.72%
-1.53%
-3.91%
30.00B
Technology
Delta Air Lines
5.58%
-0.46%
-1.43%
38.99B
Industrials
Plug Power
5.21%
-0.33%
+0.13%
1.79B
Industrials
UiPath
3.62%
-1.25%
-2.80%
7.36B
Technology
Lam Research
3.60%
-0.48%
+8.92%
101.92B
Technology
Based on the activity of 766,001 active portfolios
Open your Smart Portfolio

GLUE Investor Analysis

GLUE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.2%
of GLUE holders
are under 35
Average Segment Performance
Average P/E Ratio23.45
Beta10.33
Dividend Yield51.46%
GLUE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.5%
of GLUE holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.88
Beta20.26
Dividend Yield24.92%
GLUE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.4%
of GLUE holders
are over 55
Average Segment Performance
Average P/E Ratio21.22
Beta8.93
Dividend Yield41.53%
Overview of age group and performance of GLUE stock investors
See who invests in GLUE according to age group and performance.

FAQ

How many retail Investors hold GLUE?
<0.1% of TipRanks' retail investors hold GLUE in their portfolios.
    What is GLUE Investor Sentiment?
    GLUE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GLUE in the last 7 days?
      ▲ 2.2% of TipRanks' retail investors changed their holding of GLUE in the last 7 days.
        What percentage of retail investors changed their holding of GLUE in the last 30 days?
        ▲ 7.8% of TipRanks' retail investors changed their holding of GLUE in the last 30 days.
          What is the average age of retail investors who hold GLUE?
          The average age of GLUE Holders is between 35–55.
            What other stocks have GLUE investors also bought?
            GLUE Investors also bought VKTX, ABT, CAT, ENPH, SNPS, ZS, DAL, PLUG, PATH, LRCX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AGENAgenus
              BDXBecton Dickinson
              CPRXCatalyst Pharma
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis